Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial Post author:Sam Post published:February 5, 2018 Post category:BioPharma The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace You Might Also Like 2 Biotechs That Could Vanish by 2019 March 13, 2017 Varian Medical Systems Release: Treatments Commence With Varian Truebeam Systems At New London Hospital January 30, 2017 Verastem Reports Year-End 2016 Financial Results March 23, 2017
Varian Medical Systems Release: Treatments Commence With Varian Truebeam Systems At New London Hospital January 30, 2017
